FTSE All-Share
5.600,88
PKT
-179,37
PKT
-3,10
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.10.25 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 31.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 31.10.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 30.10.25 | Shell (ex Royal Dutch Shell) Kaufen | DZ BANK | |
| 30.10.25 | GSK Halten | DZ BANK | |
| 30.10.25 | Rio Tinto Neutral | UBS AG | |
| 30.10.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 30.10.25 | GSK Hold | Deutsche Bank AG | |
| 30.10.25 | GSK Neutral | UBS AG | |
| 30.10.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.10.25 | HSBC Sector Perform | RBC Capital Markets | |
| 30.10.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 29.10.25 | HSBC Neutral | JP Morgan Chase & Co. | |
| 29.10.25 | HSBC Hold | Deutsche Bank AG | |
| 29.10.25 | GSK Outperform | Bernstein Research | |
| 29.10.25 | GSK Neutral | UBS AG | |
| 29.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 29.10.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.10.25 | HSBC Overweight | Barclays Capital | |
| 28.10.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 28.10.25 | HSBC Neutral | UBS AG | |
| 28.10.25 | HSBC Sector Perform | RBC Capital Markets | |
| 28.10.25 | HSBC Overweight | Barclays Capital | |
| 28.10.25 | HSBC Neutral | JP Morgan Chase & Co. | |
| 28.10.25 | HSBC Hold | Jefferies & Company Inc. | |
| 27.10.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 27.10.25 | Glencore Neutral | JP Morgan Chase & Co. | |
| 27.10.25 | Unilever Kaufen | DZ BANK | |
| 27.10.25 | HSBC Neutral | JP Morgan Chase & Co. | |
| 27.10.25 | GSK Hold | Deutsche Bank AG | |
| 27.10.25 | London Stock Exchange (LSE) Buy | Deutsche Bank AG | |
| 27.10.25 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 27.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 27.10.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 27.10.25 | Unilever Underperform | RBC Capital Markets | |
| 24.10.25 | Unilever Buy | Deutsche Bank AG | |
| 24.10.25 | London Stock Exchange (LSE) Buy | Deutsche Bank AG | |
| 24.10.25 | GSK Neutral | UBS AG | |
| 24.10.25 | London Stock Exchange (LSE) Buy | UBS AG | |
| 24.10.25 | AstraZeneca Overweight | JP Morgan Chase & Co. |